Search by Drug Name or NDC
NDC 00143-9754-25 Methylprednisolone Sodium Succinate 125 mg/1 Details
Methylprednisolone Sodium Succinate 125 mg/1
Methylprednisolone Sodium Succinate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is METHYLPREDNISOLONE SODIUM SUCCINATE.
MedlinePlus Drug Summary
Methylprednisolone injection is used to treat severe allergic reactions. Methylprednisolone injection is used in the management of multiple sclerosis (a disease in which the nerves do not function properly), lupus (a disease in which the body attacks many of its own organs), gastrointestinal disease, and certain types of arthritis. Methylprednisolone injection is also used to treat certain conditions that affect the blood, skin, eyes, nervous system, thyroid, kidneys, and lungs. It is sometimes used in combination with other medications to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Methylprednisolone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.
Related Packages: 00143-9754-25Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Methylprednisolone Injection
Product Information
| NDC | 00143-9754 |
|---|---|
| Product ID | 0143-9754_bb761096-c2a1-435a-8eaf-a14d1211909a |
| Associated GPIs | |
| GCN Sequence Number | 006730 |
| GCN Sequence Number Description | methylprednisolone sod succ VIAL 125 MG INJECTION |
| HIC3 | P5A |
| HIC3 Description | GLUCOCORTICOIDS |
| GCN | 27031 |
| HICL Sequence Number | 002876 |
| HICL Sequence Number Description | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Methylprednisolone Sodium Succinate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methylprednisolone Sodium Succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203125 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9754-25 (00143975425)
| NDC Package Code | 0143-9754-25 |
|---|---|
| Billing NDC | 00143975425 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9754-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0143-9754-01) |
| Marketing Start Date | 2022-09-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |